BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 20015770)

  • 21. [Relevant factors and management for patients with squamous carcinoma in tongue without clinical cervical lymphatic node metastasis].
    Lin GC; Qiu WL; Zhang ZY; Zhang CP; Zu HG; Sun J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):5-8. PubMed ID: 12760766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.
    Gross ND; Ellingson TW; Wax MK; Cohen JI; Andersen PE
    Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):169-73. PubMed ID: 14967745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radical versus modified neck dissection. Cancer-related and functional viewpoints].
    Mann W; Wolfensberger M; Füller U; Beck C
    Laryngorhinootologie; 1991 Jan; 70(1):32-5. PubMed ID: 2025344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
    J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic significance of extra-capsular invasion in cervical lymph node metastases of squamous epithelial carcinoma].
    Steinhart H; Schroeder HG; Buchta B; Schmidt A; Kleinsasser O
    Laryngorhinootologie; 1994 Dec; 73(12):620-5. PubMed ID: 7840823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
    Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
    Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neck recurrence after level I-IV or I-III selective neck dissection in the management of the clinically N0 neck in patients with oral squamous cell carcinoma.
    Bajwa MS; McMillan R; Khattak O; Thomas M; Krishnan OP; Webster K
    Head Neck; 2011 Mar; 33(3):403-6. PubMed ID: 20629073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC; Koo BS; Lee JS; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of selective neck dissection in the treatment of the clinically positive neck.
    Patel RS; Clark JR; Gao K; O'Brien CJ
    Head Neck; 2008 Sep; 30(9):1231-6. PubMed ID: 18642289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of lymph nodes in head and neck melanoma: a retrospective study of 25 cases].
    Ricard AS; Majoufre-Lefebvre C; Delaunay M; Siberchicot F; Zwetyenga N
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):505-8. PubMed ID: 17900640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?
    Lim YC; Lee JS; Choi EC
    Acta Otolaryngol; 2009 Jan; 129(1):57-61. PubMed ID: 18607981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
    Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
    Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging.
    Ljumanovic R; Langendijk JA; Hoekstra OS; Leemans CR; Castelijns JA
    Eur J Radiol; 2006 Oct; 60(1):58-66. PubMed ID: 16829010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Head and neck squamous cell carcinoma: sentinel node or selective neck dissection.
    Kovács AF
    Surg Oncol Clin N Am; 2007 Jan; 16(1):81-100. PubMed ID: 17336238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma.
    Ebrahimi A; Clark JR; Zhang WJ; Elliott MS; Gao K; Milross CG; Shannon KF
    Head Neck; 2011 Sep; 33(9):1245-51. PubMed ID: 20967874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
    Lango MN; Andrews GA; Ahmad S; Feigenberg S; Tuluc M; Gaughan J; Ridge JA
    Head Neck; 2009 Mar; 31(3):328-37. PubMed ID: 18853450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinicopathological study on patterns of cervical lymph node metastases from squamous cell carcinomas (SCC) of the head and neck].
    Li X; Li L; Wei W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):206-9. PubMed ID: 9642343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.